MedTrace Logo

Yttrium-90 Carbon Microspheres in Patients With Unresectable Colorectal Liver Metastases

NCT05692037 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-01-30

No results posted yet for this study

Summary

To evaluate the efficacy and safety of yttrium-90 carbon microspheres in patients with unresectable colorectal liver metastases

Conditions

  • Unresectable Colorectal Liver Metastases

Interventions

COMBINATION_PRODUCT

Selective internal radiation therapy (SIRT) with yttrium-90 carbon microspheres

Yttrium-90 carbon microspheres SIRT

Sponsors & Collaborators

  • Zhongda Hospital

    lead OTHER

Principal Investigators

  • Gao-Jun Teng, MD · Zhongda Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-28
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05692037 on ClinicalTrials.gov